Suzanne S. Bowker

Discovery of a Potent, Selective, and Orally Bioavailable Acidic 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1) Inhibitor: Discovery of 2-[(3<i>S</i>)-1-[5-(Cyclohexylcarbamoyl)-6-propylsulfanylpyridin-2-yl]-3-piperidyl]acetic Acid (AZD4017)

James S. Scott, Suzanne S. Bowker, Joanne deSchoolmeester et al. · Journal of Medicinal Chemistry · 2012 · 62 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Discovery, synthesis and biological evaluation of novel glucokinase activators

Darren McKerrecher, Joanne V. Allen, Suzanne S. Bowker et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 55 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +9

Identification, optimisation and in vivo evaluation of oxadiazole DGAT-1 inhibitors for the treatment of obesity and diabetes

William McCoull, Matthew S. Addie, Alan M. Birch et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 44 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +10

Identification, Optimization, and Pharmacology of Acylurea GHS-R1a Inverse Agonists

William McCoull, Peter Barton, Alastair Brown et al. · Journal of Medicinal Chemistry · 2014 · 36 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Circumventing Seizure Activity in a Series of G Protein Coupled Receptor 119 (GPR119) Agonists

James S. Scott, Suzanne S. Bowker, Katy J. Brocklehurst et al. · Journal of Medicinal Chemistry · 2014 · 22 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +11